38 results on '"Trombetta, M."'
Search Results
2. PCR identification and prevalence of Eimeria species in commercial turkey flocks of the Midwestern United States
- Author
-
Duff, Audrey F., Briggs, W.N., Bielke, J.C., McGovern, K.E., Trombetta, M., Abdullah, H., Bielke, L.R., and Chasser, K.M.
- Published
- 2022
- Full Text
- View/download PDF
3. Role of monogenic diabetes genes on beta cell function in Italian patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 13
- Author
-
Bonetti, S., Zusi, C., Rinaldi, E., Boselli, ML., Csermely, A., Malerba, G., Trabetti, E., Bonora, E., Bonadonna, R.C., and Trombetta, M.
- Published
- 2022
- Full Text
- View/download PDF
4. Percutaneous Coronary Intervention (PCI) Followed by Intravascular Brachytherapy (IVBT) for Management of Stent-in-Stent Restenosis (SISR) in Patients with High-Risk Coronary Artery Disease
- Author
-
Matani, H., primary, Reddy, S., additional, Renz, P.B., additional, Wing, J., additional, Beriwal, S., additional, Lasorda, D., additional, and Trombetta, M., additional
- Published
- 2022
- Full Text
- View/download PDF
5. Droplet-based microfluidic synthesis of polyethyleneimine/hyaluronan nanogels for controlled drug delivery: tailoring nanomaterial properties via pressure-actuated tunable flow focusing junction
- Author
-
Giannitelli, S. M., Limiti, E., Mozetic, P., Pinelli, F., Han, X., Del Rio, D., Abbruzzese, F., Scialla, S., Rossi, F., Trombetta, M., Rosanò, L., Gigli, G., Zhang, Z. J., Mauri, E., and Rainer, A.
- Published
- 2022
6. 2091P Dermocosmetics in management of cancer-related skin toxicities: International expert consensus highlighting the key role of oncology nurses
- Author
-
Dielenseger, P., Lacouture, M., Khosrotehrani, K., De Barros Silva, G., Wolf, J. Ryan, Kerob, D., Trombetta, M., Atenguena, E.O., Pan, M., Scotte, F., Krakowski, I., and Dreno, B.
- Published
- 2023
- Full Text
- View/download PDF
7. PCR identification and prevalence of Eimeriaspecies in commercial turkey flocks of the Midwestern United States
- Author
-
Duff, Audrey F., Briggs, W.N., Bielke, J.C., McGovern, K.E., Trombetta, M., Abdullah, H., Bielke, L.R., and Chasser, K.M.
- Abstract
The present study used a PCR approach to characterize prevalence of coccidial species in fecal samples obtained from 40 individual Midwestern turkey flocks to characterize distribution of species in commercial flocks. Each sample was screened for six prominent Eimeriaspecies using species-specific primers and were supplemented with a primary nested-PCR approach for amplification of mitochondrial cytochrome C oxidase subunit gene I where initial sample DNA concentrations were low. All samples were positive for at least one species of Eimeria, while most presented 2 (20/40) or 3 (14/40) species in total. Prevalence across farms was primarily dominated by E. meleagrimitis(97.50%), E. adenoides(95%), and E. gallopavonis(40%). Of the samples positive for E. adenoidesand E. meleagrimitis, almost half (17/40) contained additional species. Data presented here offer insight into Eimeriaspecies currently challenging the Midwestern U.S. turkey industry and potential need to evaluate flocks for species prior to implementing vaccination programs.
- Published
- 2022
- Full Text
- View/download PDF
8. Active breaks: a strategy to counteract sedentary behaviors for Health Promoting Schools. A discussion on their implementation in Italy
- Author
-
L. Dallolio, F. Gallè, A. Masini, F. Valeriani, A. Ceciliani, A. di Cagno, D. Galeone, P. Pecoraro, G. Valerio, G. Liguori, V. Romano Spica, G. Brandi, G. Baldelli, G. Capelli, D. Coco, M. Corradi, E. Cortis, P. Deiana, E. Di Rosa, S. Marini, R. Mulato8, A. Parisi, C. Pesce, S. Riegger, A. Staiano, A. Siniscalco, M. Trombetta, F. Ubaldi., L. Dallolio, F. Gallè , A. Masini, F. Valeriani, A. Ceciliani , A. di Cagno, D. Galeone, P. Pecoraro, G. Valerio, G. Liguori, V. Romano Spica, G. Brandi, G. Baldelli, G. Capelli, D. Coco, M. Corradi, E. Cortis, P. Deiana, E. Di Rosa, S. Marini, R. Mulato, A. Parisi, C. Pesce, S. Riegger, A. Staiano, A. Siniscalco, M. Trombetta, F. Ubaldi, Dallolio, L., Gallè, F., Masini, A., Valeriani, F., Ceciliani, A., di Cagno, A., Galeone, D., Pecoraro, P., Valerio, G., Liguori, G., Romano Spica, V., Brandi, G., Baldelli, G., Capelli, G., Coco, D., Corradi, M., Cortis, E., Deiana, P., Di Rosa, E., Marini, S., Mulato8, R., Parisi, A., Pesce, C., Riegger, S., Staiano, A., Siniscalco, A., Trombetta, M., and Ubaldi., F.
- Subjects
Active breaks, health, school ,Pause attive, scuola, salute [Active breaks, school, health Parole chiave] ,School, Active Breaks, physical activity ,Active breaks ,school ,scuola ,health ,Pause attive [health Parole chiave] ,salute - Abstract
School Active Breaks are short bouts of physical activity (5-15 minutes) conducted by appropriately trained teachers and delivered during or between curricular lessons. They are a good strategy to counteract sedentary behaviors, and a growing body of evidence shows that they can represent also a tool to promote and improve health, school wellbeing and academic achievements. On 19 February 2022, the Working Group on Movement Sciences for Health of the Italian Society of Hygiene, Preventive Medicine and Public Health organized an Awareness Day on the effectiveness, usefulness and feasibility of School Active Breaks, opened to teachers, educators, school leaders, pediatricians, personnel from Departments of Prevention and Public Health and Health Policy-makers. During the event, the testimonies about the experiences already carried out in Italy showed that School Active Breaks are an effective intervention that each school can easily include in its educational offer and apply in any context.
- Published
- 2023
9. Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis
- Author
-
Claudia Piona, Enza Mozzillo, Antonella Tosco, Sonia Volpi, Francesco Maria Rosanio, Chiara Cimbalo, Adriana Franzese, Valeria Raia, Chiara Zusi, Federica Emiliani, Maria Linda Boselli, Maddalena Trombetta, Riccardo Crocina Bonadonna, Marco Cipolli, Claudio Maffeis, Piona, C., Mozzillo, E., Tosco, A., Volpi, S., Rosanio, F. M., Cimbalo, C., Franzese, A., Raia, V., Zusi, C., Emiliani, F., Boselli, M. L., Trombetta, M., Bonadonna, R. C., Cipolli, M., and Maffeis, C.
- Subjects
cystic fibrosis ,elexacaftor-ivacaftor-tezacaftor ,cftr modulator ,β-cell function ,cftr modulators ,lumacaftor/ivacaftor ,oral glucose tolerance test ,glucose metabolism ,insulin clearance ,insulin sensitivity ,General Medicine ,cystic fibrosi - Abstract
Background: To date, no consistent data are available on the possible impact of CFTR modulators on glucose metabolism. The aim of this study was to test the hypothesis that treatment with CFTR modulators is associated with an improvement in the key direct determinants of glucose regulation in children and young adults affected by Cystic Fibrosis (CF). Methods: In this study, 21 CF patients aged 10–25 underwent oral glucose tolerance test (OGTT) before and after 12–18 months of treatment with Lumacaftor/Ivacaftor or Elexacaftor-Ivacaftor-Tezacaftor. β-cell function (i.e., first and second phase of insulin secretion measured as derivative and proportional control, respectively) and insulin clearance were estimated by OGTT mathematical modelling. Insulin sensitivity was estimated by the Oral Glucose Sensitivity Index (OGIS). The dynamic interplay between β-cell function, insulin clearance and insulin sensitivity was analysed by vector plots of glucose-stimulated insulin bioavailability vs. insulin sensitivity. Results: No changes in glucose tolerance occurred after either treatment, whereas a significant improvement in pulmonary function and chronic bacterial infection was observed. Beta cell function and insulin clearance did not change in both treatment groups. Insulin sensitivity worsened in the Lumacaftor/Ivacaftor group. The analysis of vector plots confirmed that glucose regulation was stable in both groups. Conclusions: Treatment of CF patients with CFTR modulators does not significantly ameliorate glucose homeostasis and/or any of its direct determinants.
- Published
- 2022
10. Different Times for Different Metrics: Predicting 90 Days of Intermittently Scanned Continuous Glucose Monitoring Data in Subjects With Type 1 Diabetes on Multiple Daily Injection Therapy. Findings From a Multicentric Real-World Study.
- Author
-
Csermely A, Borella ND, Turazzini A, Pilati M, Sheiban SS, Bonadonna RC, Trevisan R, Trombetta M, and Lepore G
- Abstract
Aims: According to the 2023 International Consensus, glucose metrics derived from two-week-long continuous glucose monitoring (CGM) can be extrapolated up to 90 days before. However, no studies have focused on adults with type 1 diabetes (T1D) on multiple daily injections (MDIs) and with second-generation intermittently scanned CGM (isCGM) sensors in a real-world setting., Methods: This real-world, retrospective study included 539 90-day isCGM data from 367 adults with T1D on MDI therapy. For each sensor metric, the coefficients of determination ( R
2 ) were computed for sampling periods from 2 to 12 weeks versus the whole 90-day interval. Correlations were considered strong for R2 ≥0.88., Results: The two-week sampling period displayed strong correlations for time in range (TIR, 70-180 mg/dl; R2 = 0.89) and above range (TAR, >180 mg/dl; R2 = 0.88). The four-week sampling period showed additional strong correlations for time in tight range (TITR, 70-140 mg/dl; R2 = 0.92), for the coefficient of variation (CV; R2 = 0.88), and for the glycemia risk index (GRI; R2 = 0.92). The six-week sampling period displayed an additional strong correlation for time below range (TBR, <70 mg/dl; R2 = 0.90). After stratification by clinical variables, lower R2 values were found for older age quartiles (>40 years), higher CV (>36%), lower sensor use (≤94%), and higher HbA1c (>7.5%)., Conclusion: In patients with T1D on MDI, two- to six-week intervals of isCGM use can provide clinically useful estimates of TIR, TAR, TITR, TBR, CV, and GRI, which can be extrapolated to longer (up to 90 days) time intervals. Longer intervals might be needed in case of older age, higher glucose variability, lower sensor use, and higher HbA1c., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.- Published
- 2025
- Full Text
- View/download PDF
11. Interactions of the Osteokines, Glucose/Insulin System and Vascular Risk Networks in Patients With Newly Diagnosed Type 2 Diabetes (VNDS 15).
- Author
-
Zusi C, Bonetti S, Rinaldi E, Csermely A, Boselli ML, Travia D, Santi L, Bonora E, Bonadonna RC, and Trombetta M
- Subjects
- Aged, Female, Humans, Male, Middle Aged, Biomarkers blood, Diabetic Angiopathies etiology, Diabetic Angiopathies blood, Diabetic Angiopathies diagnosis, Follow-Up Studies, Insulin blood, Prognosis, RANK Ligand blood, Risk Factors, Blood Glucose analysis, Blood Glucose metabolism, Diabetes Mellitus, Type 2 blood, Diabetes Mellitus, Type 2 metabolism, Diabetes Mellitus, Type 2 complications, Insulin Resistance, Osteocalcin blood, Osteopontin blood, Osteoprotegerin blood
- Abstract
Background and Aim: Bone as an endocrine organ regulates metabolic processes independently of mineral metabolism through the production/release of proteins collectively named 'osteokines'. Relevant connections were reported between the insulin/glucose system, calcification of the atherosclerotic plaque, and several osteokines. We aimed to test the hypothesis that the osteokine network could be involved in beta-cell function, insulin sensitivity, and vascular damage in a cohort of people with newly diagnosed type 2 diabetes (T2D)., Subjects and Methods: In 794 drug-naive, GADA-negative, newly-diagnosed T2D patients (mean ± SD age: 59 ± 9.8 years; BMI: 29.3 ± 5.3 kg/m
2 ; HbA1c: 6.6 ± 1.3%) we assessed: plasma concentration of osteocalcin (OCN), osteopontin (OPN), RANKL, and its putative decoy receptor osteoprotegerin (OPG); insulin sensitivity (SI) by hyperinsulinemic euglycemic clamp; beta cell function (BCF), estimated by OGTT minimal modelling and expressed as derivative (DC) and proportional (PC) control. Echo-doppler of carotid and lower limb arteries were also performed in 708 and 701 subjects, respectively., Results: OCN, RANKL and OPG were significantly associated with PC (p < 0.02); OCN was positively related to DC (p = 0.018). OPG was associated with lower IS (p < 0.001). Finally, the higher RANKL levels, the greater was the severity of atherosclerosis in common carotid artery (p < 0.001). Increased OPG and OPN concentrations were related to subclinical atherosclerosis in peripheral arteries of lower limbs (p = 0.023 and p = 0.047, respectively)., Conclusion: These data suggest that, in patients with newly diagnosed T2D, the osteokine network crosstalks with the glucose/insulin system and may play a role in modulating the atherosclerotic process., (© 2024 The Author(s). Diabetes/Metabolism Research and Reviews published by John Wiley & Sons Ltd.)- Published
- 2024
- Full Text
- View/download PDF
12. Nanoscopic gel particle for intra-articular injection formulation.
- Author
-
Han X, Scialla S, Limiti E, Davis ET, Trombetta M, Rainer A, Jones SW, Mauri E, and Zhang ZJ
- Subjects
- Injections, Intra-Articular methods, Humans, Nanoparticles chemistry, Nanoparticles administration & dosage, Nanogels chemistry, Animals, Drug Delivery Systems methods, Hydrogels chemistry, Cartilage, Articular drug effects, Particle Size, Hyaluronic Acid chemistry, Hyaluronic Acid administration & dosage, Polyethyleneimine chemistry
- Abstract
Hyaluronic acid (HA) based nanogels showed effective intracellular delivery efficacy for anti-cancer and anti-inflammatory drugs, characterized by their ability targeting relevant cell receptors. In the present study, we demonstrate the ability of hyaluronic acid-polyethyleneimine (HA-PEI) nanogels as a promising dual-functional interfacial active for intra-articular injection to intervene arthritis. Nanomechanical measurements on both model substrates and human cartilage samples confirm that the HA-PEI nanogels can significantly improve interfacial lubrication, in comparison to HA molecules, or silica-based nanoparticles. We show that the Coefficient of Friction significantly decreases with a decreasing nanogel size. The exceptional lubricating performance, coupled with the proven drug delivery capability, evidences the great potential of nanoscopic hydrogels for early-stage arthritis treatment. The flexibility in choosing the chemical nature, molecular architecture, and structural characteristics of nanogels makes it possible to modulate both drug delivery kinetics and interfacial lubrication, thus representing an innovative approach to treat degenerative joint diseases., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
13. Design, Calibration and Morphological Characterization of a Flexible Sensor with Adjustable Chemical Sensitivity and Possible Applications to Sports Medicine.
- Author
-
Zompanti A, Basoli F, Saggio G, Mattioli F, Sabatini A, Grasso S, Marino M, Longo UG, Trombetta M, and Santonico M
- Subjects
- Calibration, Humans, Equipment Design, Carbon Dioxide analysis, Carbon Dioxide chemistry, Oxygen chemistry, Oxygen analysis, Biosensing Techniques methods, Sports Medicine methods
- Abstract
Active life monitoring via chemosensitive sensors could hold promise for enhancing athlete monitoring, training optimization, and performance in athletes. The present work investigates a resistive flex sensor (RFS) in the guise of a chemical sensor. Its carbon 'texture' has shown to be sensitive to CO
2 , O2 , and RH changes; moreover, different bending conditions can modulate its sensitivity and selectivity for these gases and vapors. A three-step feasibility study is presented including: design and fabrication of the electronic read-out and control; calibration of the sensors to CO2 , O2 and RH; and a morphological study of the material when interacting with the gas and vapor molecules. The 0.1 mm-1 curvature performs best among the tested configurations. It shows a linear response curve for each gas, the ranges of concentrations are adequate, and the sensitivity is good for all gases. The curvature can be modulated during data acquisition to tailor the sensitivity and selectivity for a specific gas. In particular, good results have been obtained with a curvature of 0.1 mm-1 . For O2 in the range of 20-70%, the sensor has a sensitivity of 0.7 mV/%. For CO2 in the range of 4-80%, the sensitivity is 3.7 mV/%, and for RH the sensitivity is 33 mV/%. Additionally, a working principle, based on observation via scanning electron microscopy, has been proposed to explain the chemical sensing potential of this sensor. Bending seems to enlarge the cracks present in the RFS coverage; this change accounts for the altered selectivity depending on the sensor's curvature. Further studies are needed to confirm result's reliability and the correctness of the interpretation.- Published
- 2024
- Full Text
- View/download PDF
14. A Randomized Crossover Trial Comparing Glucose Control During Postprandial Moderate Aerobic Activity and High-Intensity Interval Training in Adults With Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System.
- Author
-
Da Prato G, Csermely A, Pilati M, Carletti L, Rinaldi E, Donà S, Santi L, Negri C, Bonora E, Moghetti P, and Trombetta M
- Subjects
- Adult, Female, Humans, Male, Blood Glucose Self-Monitoring, Cross-Over Studies, Glycemic Control methods, Hypoglycemic Agents administration & dosage, Insulin administration & dosage, Insulin Infusion Systems, Blood Glucose analysis, Blood Glucose metabolism, Diabetes Mellitus, Type 1 blood, Diabetes Mellitus, Type 1 drug therapy, Exercise physiology, High-Intensity Interval Training methods, Postprandial Period
- Abstract
Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
15. A longitudinal study of glucose tolerance in cystic fibrosis: the central role of beta cell functional mass.
- Author
-
Piona C, Mozzillo E, Tosco A, Zusi C, Emiliani F, Volpi S, Di Candia F, Raia V, Boselli ML, Trombetta M, Cipolli M, Bonadonna RC, and Maffeis C
- Abstract
Context: The pathophysiological mechanisms underlying the natural history of glucose intolerance and its fluctuations in subjects with cystic fibrosis (CF) are still unclear., Objective: To investigate the relationship between longitudinal changes in glucose tolerance and concomitant changes in the main parameters of insulin secretion/metabolism/action determining glucose regulation in CF subjects., Methods: Insulin sensitivity and glucose-stimulated insulin secretion (GSIS, a biomarker of beta cell functional mass), as estimated by the Oral Glucose Sensitivity Index (OGIS) and by a sophisticated mathematical model, respectively, and insulin clearance were assessed in 127 CF subjects, aged 10-25 years, who underwent two OGTT tests over at least 1-year follow-up period. Subjects were classified a posteriori as regressors (improved glucose tolerance), stable, or progressors (worsened glucose tolerance). The interplay between beta cell compensatory action and insulin sensitivity over time was analyzed by vector plots of insulin clearance adjusted GSIS (PCadj) versus OGIS., Results: OGIS decreased in progressors and stable. Insulin clearance decreased in both regressors and progressors. GSIS (beta cell functional mass) improved in regressors and worsened in progressors, whereas it did not change in stable. Vector plot analysis confirmed that glucose regulation changed differently in each group. Multinomial logistic regression analysis showed that baseline glucose tolerance and GSIS changes were the only significant predictors of the changes in glucose tolerance (p<0.02, R2Nagelkerke=0.55), whereas age, gender, z-BMI, CF genotypes, and baseline PCadj were not., Conclusions: In CF subjects, changes in beta cell functional mass are associated with favorable or detrimental changes of glucose tolerance over time., (© The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. See the journal About page for additional terms.)
- Published
- 2024
- Full Text
- View/download PDF
16. An unusual "linitis plastica" like breast cancer bladder metastasis.
- Author
-
Farci R, Tolu S, Trombetta M, Murgia A, and Solinas A
- Subjects
- Humans, Female, Middle Aged, Hematuria etiology, Urinary Bladder Neoplasms pathology, Urinary Bladder Neoplasms secondary, Breast Neoplasms pathology, Linitis Plastica secondary
- Abstract
Breast cancer (BrC) is the most frequently diagnosed malignancy in woman and most BrC related deaths are due to metastasis. BrC frequently metastasizes to the lymph nodes, liver, lung, bone and brain while the urinary bladder is considered as an unusual site for breast metastasis. We report a case of bladder metastasis identified in a patient with past BrC history, presenting with hematuria, low urinary tract symptoms, and hydronephrosis.
- Published
- 2024
- Full Text
- View/download PDF
17. On the compatibility of single-cell microcarriers (nanovials) with microfluidic impedance cytometry.
- Author
-
Brandi C, De Ninno A, Ruggiero F, Limiti E, Abbruzzese F, Trombetta M, Rainer A, Bisegna P, and Caselli F
- Subjects
- Humans, Electric Impedance, Nanostructures chemistry, Flow Cytometry instrumentation, Mesenchymal Stem Cells cytology, Single-Cell Analysis instrumentation, Microfluidic Analytical Techniques instrumentation
- Abstract
We investigate for the first time the compatibility of nanovials with microfluidic impedance cytometry (MIC). Nanovials are suspendable crescent-shaped single-cell microcarriers that enable specific cell adhesion, the creation of compartments for undisturbed cell growth and secretion, as well as protection against wall shear stress. MIC is a label-free single-cell technique that characterizes flowing cells based on their electrical fingerprints and it is especially targeted to cells that are naturally in suspension. Combining nanovial technology with MIC is intriguing as it would represent a robust framework for the electrical analysis of single adherent cells at high throughput. Here, as a proof-of-concept, we report the MIC analysis of mesenchymal stromal cells loaded in nanovials. The electrical analysis is supported by numerical simulations and validated by means of optical analysis. We demonstrate that the electrical diameter can discriminate among free cells, empty nanovials, cell-loaded nanovials, and clusters, thus grounding the foundation for the use of nanovials in MIC. Furthermore, we investigate the potentiality of MIC to assess the electrical phenotype of cells loaded in nanovials and we draw directions for future studies.
- Published
- 2024
- Full Text
- View/download PDF
18. Patient-reported experience with the use of Mepitel Film for prevention of acute radiation dermatitis in breast cancer.
- Author
-
Gojsevic M, Kennedy S, Rajeswaran T, Herst P, Safavi AH, Corbin K, Hill R, Tran W, Carothers K, Gallant F, Trombetta M, Arscott WT, Shariati S, Lam J, Akkila S, Behroozian T, Zhang E, Karam I, and Chow E
- Subjects
- Humans, Female, Skin, Patient Reported Outcome Measures, Breast Neoplasms radiotherapy, Radiodermatitis prevention & control
- Abstract
Background and Purpose: Mepitel Film (MF) has been demonstrated to reduce the severity of radiation dermatitis (RD) in patients receiving breast cancer radiotherapy (RT). The objective of this study was to characterize patient-reported experience with MF use, including its impact on daily activities and wellbeing., Materials and Methods: This single-institution study analyzed anonymized responses to a questionnaire completed by patients who used MF for the prevention of RD during breast cancer RT., Results: Of the 254 patients contacted, 192 patients completed the survey. Most patients disagreed or strongly disagreed that MF limited their ability to perform their daily activities, including household chores (88%, n = 169/191), their ability to work (83%, n = 157/189), or their ability to sleep (85%, n = 163/191). Furthermore, patients agreed or strongly agreed MF was comfortable on their skin (67%, n = 126/189) and protected their skin from rubbing against clothing (86%, n = 161/188). Some patients agreed or strongly agreed that MF affected their ability to shower (31%, n = 50/162), wear bras (28%, n = 51/185), and impacted their level of pruritus (35%, n = 67/189). However, most patients agreed or strongly agreed that their overall experience with MF was positive (92%, n = 173/189) and would recommend MF to a friend undergoing breast cancer RT (88%, n = 166/188)., Conclusion: MF use is associated with positive patient-reported experience during breast RT with minimal impact on daily activities., (© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
19. Perceptions of healthcare professionals on the use of Mepitel Film for the prevention of acute radiation dermatitis in breast cancer.
- Author
-
Rajeswaran T, Kennedy SKF, Gojsevic M, Herst P, Safavi AH, Corbin K, Hill R, Karam I, Tran W, Gallant F, Carothers K, Lam J, Trombetta M, Arscott WT, Shariati S, Akkila S, Behroozian T, Zhang E, and Chow E
- Subjects
- Humans, Female, Mastectomy, Health Personnel, Delivery of Health Care, Breast Neoplasms radiotherapy, Radiodermatitis prevention & control
- Abstract
Introduction: Randomized clinical trials support Mepitel Film (MF) as a prophylactic treatment for radiation dermatitis (RD) in patients undergoing breast radiotherapy. Although several studies have canvassed the opinion of patients on using MF, no such studies have been done to investigate the perception of healthcare professionals (HCPs). The objective of this study was therefore to investigate the perceptions of HCPs on MF as a treatment option for RD., Methods: Anonymized responses to a web-based survey sent to HCPs at a single institution managing patients using MF during breast radiotherapy were analyzed., Results: Of the 28 HCPs contacted, 22 completed the survey, including 6 radiation oncologists (ROs), 11 radiation therapists (RTTs), and 5 nurses. Most HCPs reported MF was better at preventing severe RD than the standard of care and improved radiation-induced skin reactions (n = 20/22, 91%, and n = 19/22, 86%, respectively). MF was recommended for mastectomy patients without reconstruction (n = 15/21, 71%). The majority of HCPs believed that patients' families could be trained to apply and remove MF (n = 19/22, 86%). Many HCPs perceived that implementation of MF would be difficult in terms of maintaining patient flow and wide-scale implementation within their institution (n = 11/22, 50%, and n = 10/22, 46%, respectively). Most HCPs perceived that fewer than 50% of their patients could afford MF if priced at $100 CAD (n = 15/20, 75%)., Conclusion: These findings provide insights into the possibility of MF to be incorporated into standard practice of care for RD. Although most HCPs were satisfied with MF as a prophylactic treatment for RD, there are concerns about its resource-intensive operationalization and financial accessibility to patients. Future research should focus on ways to improve HCP experience with MF and to improve its implementation into clinical settings as standard of care., (© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
20. The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus.
- Author
-
Dreno B, Khosrotehrani K, De Barros Silva G, Wolf JR, Kerob D, Trombetta M, Atenguena E, Dielenseger P, Pan M, Scotte F, Krakowski I, and Lacouture M
- Subjects
- Humans, Consensus, Skin, Immunotherapy adverse effects, Skin Diseases, Neoplasms drug therapy, Neoplasms etiology
- Abstract
Skin toxicities are very common in patients undergoing cancer treatment and have been found to occur with all types of cancer therapeutic interventions (cytotoxic chemotherapy, targeted therapies, immunotherapy, and radiotherapy). Further, skin toxicities can lead to interruption or even discontinuation of anticancer treatment in some patients, translating to suboptimal outcomes. Dermocosmetics (or cosmeceuticals)-defined as skincare solutions incorporating dermatologically active ingredients (beyond vehicle effects) that directly improve symptoms of various skin conditions-are increasingly being used in cancer care to prevent and manage skin toxicities. The active ingredients in these products have a measurable biological action in skin; they typically improve skin integrity (barrier function/hydration and other factors) while relieving skin symptoms. The Association Francophone des Soins Oncologiques de Support (AFSOS) and Multinational Association of Supportive Care in Cancer (MASCC) partnered to select a multidisciplinary group of healthcare professionals involved in the management of patients with cancer and skin toxicities. The group reviewed existing literature and created a summary of recommendations for managing these toxicities through online meetings and communication. In this publication, the group (1) reviews new skin toxicities seen with oncology drugs and (2) evaluates the role of dermocosmetics in improving patient outcomes and minimizing cancer treatment interruptions. We provide general recommendations for initiation and selection of skin care in all oncology patients as well as recommendations for what factors should be considered when using dermocosmetics in specific types of skin toxicities., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
21. Online Adaptive MRI-Guided Stereotactic Body Radiotherapy for Pancreatic and Other Intra-Abdominal Cancers.
- Author
-
Lee D, Renz P, Oh S, Hwang MS, Pavord D, Yun KL, Collura C, McCauley M, Colonias AT, Trombetta M, and Kirichenko A
- Abstract
A 1.5T MRI combined with a linear accelerator (Unity
® , Elekta; Stockholm, Sweden) is a device that shows promise in MRI-guided stereotactic body radiation treatment (SBRT). Previous studies utilized the manufacturer's pre-set MRI sequences (i.e., T2 Weighted (T2W)), which limited the visualization of pancreatic and intra-abdominal tumors and organs at risk (OAR). Here, a T1 Weighted (T1W) sequence was utilized to improve the visualization of tumors and OAR for online adapted-to-position (ATP) and adapted-to-shape (ATS) during MRI-guided SBRT. Twenty-six patients, 19 with pancreatic and 7 with intra-abdominal cancers, underwent CT and MRI simulations for SBRT planning before being treated with multi-fractionated MRI-guided SBRT. The boundary of tumors and OAR was more clearly seen on T1W image sets, resulting in fast and accurate contouring during online ATP/ATS planning. Plan quality in 26 patients was dependent on OAR proximity to the target tumor and achieved 96 ± 5% and 92 ± 9% in gross tumor volume D90% and planning target volume D90% . We utilized T1W imaging (about 120 s) to shorten imaging time by 67% compared to T2W imaging (about 360 s) and improve tumor visualization, minimizing target/OAR delineation uncertainty and the treatment margin for sparing OAR. The average time-consumption of MRI-guided SBRT for the first 21 patients was 55 ± 15 min for ATP and 79 ± 20 min for ATS.- Published
- 2023
- Full Text
- View/download PDF
22. Stereotactic ablative radiotherapy in ventricular fibrillation with left ventricular thrombus.
- Author
-
Gupta M, Liu E, Shaw G, Oh S, Trombetta M, Sohn J, and Thosani AJ
- Abstract
Competing Interests: There are no disclosures and no conflicts for all authors.
- Published
- 2023
- Full Text
- View/download PDF
23. Crosstalk between genetic variability of adiponectin and leptin, glucose-insulin system and subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study 14.
- Author
-
Zusi C, Csermely A, Rinaldi E, Bertoldo K, Bonetti S, Boselli ML, Travia D, Bonora E, Bonadonna RC, and Trombetta M
- Subjects
- Humans, Leptin genetics, Adiponectin genetics, Triglycerides, Glucose, Diabetes Mellitus, Type 2 complications, Diabetes Mellitus, Type 2 genetics, Insulin Resistance genetics, Atherosclerosis diagnosis, Atherosclerosis genetics, Insulins
- Abstract
Aim: To evaluate the relationship of genetic variability of adiponectin (ADIPOQ), leptin (LEP) and leptin receptor (LEPR) genes with glucose-insulin system and markers of subclinical atherosclerosis (ATS) in patients with newly diagnosed type 2 diabetes., Materials and Methods: In 794 subjects we performed: 1) euglycemic hyperinsulinemic clamp to assess insulin sensitivity; 2) mathematical modelling of a 5h-OGTT to estimate β-cell function; 3) resting ECG; 4) carotid artery and lower limb artery eco-doppler sonography to identify ATS; 5) genotyping of tag-SNPs within ADIPOQ, LEP and LEPR gene., Results: Regression analyses showed: 1) adiponectin levels were negatively associated with BMI, waist-to-hip ratio and triglycerides and positively with HDL and insulin sensitivity (p-all<0.03); 2) leptin levels were positively associated with BMI, HDL-cholesterol and plasma triglycerides and negatively with insulin sensitivity (p-all<0.001). Two SNPs (rs1501299 and rs2241767) within ADIPOQ gene were associated with circulating levels of adiponectin. The ADIPOQ-GAACA haplotype was associated with plasma adiponectin (p=0.034; β=-0.24), ECG abnormalities (p=0.012; OR=2.76), carotid ATS (p=0.025; OR=2.00) and peripheral limb artery ATS (p=0.032; OR=1.90). The LEP-CTA haplotype showed an association with ischemic ECG abnormalities (p=0.017; OR=2.24). Finally, LEPR-GAACGG was associated with circulating leptin (p=0.005; β=-0.31) and worst β-cell function (p=0.023; β=-15.10). Omnibus haplotype analysis showed that ADIPOQ haplotypes were associated with levels of adiponectin and common carotid artery ATS, LEP with peripheral limb artery ATS, whereas LEPR haplotypes influenced circulating levels of leptin., Conclusions: Results of this study reinforce knowledge on adipokines' role in regulating glucose metabolism; in particular highlighted the potential atherogenic role of leptin and the anti atherogenic role of adiponectin., (© 2023 John Wiley & Sons Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
24. Adapted tissue assay for the assessment of ileal granulocyte degranulation following in ovo inoculation with select bacteria or coccidial challenge in chickens.
- Author
-
Duff AF, Chasser KM, McGovern KE, Trombetta M, and Bielke LR
- Subjects
- Animals, Chickens, Ileum, Weight Gain, Body Weight, Coccidiosis veterinary, Eimeria, Lactobacillales, Poultry Diseases microbiology
- Abstract
A previously described heterophil degranulation assay was adapted for use with ileal mucosal tissue via quantification of β-D-glucuronidase and assay end product 4-methylumbelliferone (4-MU). Three initial experiments evaluated the effect of in ovo inoculations of Citrobacter freundii (CF) or mixed lactic acid bacteria (LAB) on ileal granulocyte degranulation. Inoculations were administered on embryonic d18, body weights (BW) were recorded on day of hatch (DOH) and d10 to calculate body weight gain (BWG), and ileal mucosal scrapings were collected on DOH or d10 for the 4-MU assay. In all experiments, treatments were statistically analyzed relative to control groups. Treatments minimally affected BWG in all in ovo experiments (p > 0.05) relative to respective control groups. Similarly, ileal degranulation in in ovo treatments did not statistically differ (p > 0.05). Based on BWG, in ovo treatments may have induced low-level inflammation unable to elicit detectable changes via the 4-MU assay. Four subsequent experiments were conducted to evaluate effects of Eimeria maxima (EM) on ileal degranulation. Treatments included non-inoculated controls and low, medium, or high EM infection. Across all four experiments, final BW or BWG over the inoculation period were suppressed (p < 0.05) in EM groups relative to respective controls with the exception of EM-low (p = 0.094) and EM-medium (p = 0.096) in one trial. Ileal mucosal scrapings for the 4-MU assay were collected on day of peak lesions. Resulting values were reduced (p < 0.05) for EM treated birds in three experiments with the exception of EM-medium (p = 0.247). No differences were observed in one experiment (p = 0.351), which may have been attributed to a variation in strain of infecting Eimeria. Although refinement for low level inflammation is warranted, results indicate successful adaptation of the 4-MU assay for use with intestinal tissue during significant gastrointestinal inflammation., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2023 Duff et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2023
- Full Text
- View/download PDF
25. Correction to: Assessing attitudes towards insulin pump therapy in adults with type 1 diabetes: Italian validation of the Insulin Pump Attitudes Questionnaire (IT‑IPA questionnaire).
- Author
-
Messina R, Indelicato L, Iommi M, Trombetta M, Roos T, Hermanns N, Di Sipio A, Fantini MP, and Calvo V
- Published
- 2023
- Full Text
- View/download PDF
26. Topical corticosteroids for the prevention of severe radiation dermatitis: a systematic review and meta-analysis.
- Author
-
Tam S, Zhou G, Trombetta M, Caini S, Ryan Wolf J, van den Hurk C, Beveridge M, Lam H, Bonomo P, Chow E, and Behroozian T
- Subjects
- Humans, Betamethasone, Adrenal Cortex Hormones therapeutic use, Dermatologic Agents adverse effects, Radiodermatitis prevention & control
- Abstract
Purpose: Radiation dermatitis (RD) is a frequently occurring adverse reaction during radiotherapy in cancer patients. While the use of topical corticosteroids (TCs) is common for the treatment of RD, its role in preventing severe reactions remains unclear. This systematic review and meta-analysis aim to evaluate the evidence on the use of TCs as prophylaxis of RD., Methods: A systematic search was conducted using OVID MedLine, Embase, and Cochrane databases (between 1946 and 2023) to identify studies examining TC use in the prevention of severe RD. Statistical analysis was completed using RevMan 5.4 to calculate pooled effect sizes and 95% confidence intervals. Forest plots were then developed using a random effects model., Results: Ten RCTs with a total of 1041 patients met the inclusion criteria. Six studies reported on mometasone furoate (MF) and four studies reported on betamethasone. Both TCs were associated with a significant improvement in the prevention of moist desquamation [OR = 0.34, 95% CI [0.25, 0.47], p < 0.00001], but betamethasone was found to be more effective than MF [OR = 0.29, 95% CI [0.18, 0.46], p < 0.00001 and OR = 0.39, 95% CI [0.25, 0.61], p < 0.0001, respectively]. A similar finding was seen in reducing the development of grade 2 or higher RD according to the Radiation Therapy Oncology Group scale., Conclusions: The current evidence supports the use of TCs in preventing severe reactions of RD. Both MF and betamethasone were found to be effective; however, betamethasone, a higher potency TC, is more effective despite MF being more commonly reported in literature., (© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
27. G Protein-Coupled Receptors and the Rise of Type 2 Diabetes in Children.
- Author
-
Dallatana A, Cremonesi L, Trombetta M, Fracasso G, Nocini R, Giacomello L, and Innamorati G
- Abstract
The human genome counts hundreds of GPCRs specialized to sense thousands of different extracellular cues, including light, odorants and nutrients in addition to hormones. Primordial GPCRs were likely glucose transporters that became sensors to monitor the abundance of nutrients and direct the cell to switch from aerobic metabolism to fermentation. Human β cells express multiple GPCRs that contribute to regulate glucose homeostasis, cooperating with many others expressed by a variety of cell types and tissues. These GPCRs are intensely studied as pharmacological targets to treat type 2 diabetes in adults. The dramatic rise of type 2 diabetes incidence in pediatric age is likely correlated to the rapidly evolving lifestyle of children and adolescents of the new century. Current pharmacological treatments are based on therapies designed for adults, while youth and puberty are characterized by a different hormonal balance related to glucose metabolism. This review focuses on GPCRs functional traits that are relevant for β cells function, with an emphasis on aspects that could help to differentiate new treatments specifically addressed to young type 2 diabetes patients.
- Published
- 2023
- Full Text
- View/download PDF
28. Lower heart rate variability, an index of worse autonomic function, is associated with worse beta cell response to a glycemic load in vivo-The Maastricht Study.
- Author
-
Rinaldi E, van der Heide FC, Bonora E, Trombetta M, Zusi C, Kroon AA, Schram MT, van der Kallen CJ, Wesselius A, Bonadonna R, Mari A, Schalkwijk CG, van Greevenbroek MM, and Stehouwer CD
- Subjects
- Male, Humans, Middle Aged, Aged, Female, Blood Glucose metabolism, Heart Rate, Cohort Studies, Cross-Sectional Studies, Glucose, Diabetes Mellitus, Type 2 diagnosis, Glycemic Load
- Abstract
Objective: We investigated, using population-based data, whether worse autonomic function, estimated from lower 24-hour heart rate variability (HRV), was associated with beta cell function, assessed from beta cell response during an oral glucose tolerance test (OGTT)., Research Design and Methods: We used cross-sectional data from The Maastricht Study, a population-based cohort study (N = 2,007; age, mean ± SD:60 ± 8 years; 52% men; and 24% with type 2 diabetes). We used linear regression analyses with adjustment for potential confounders (demographic, cardiovascular, and lifestyle factors) to study the associations of time- and frequency-domain HRV (composite scores) with overall beta cell response (estimated from a composite score calculated from: C-peptidogenic index, overall insulin secretion, beta cell glucose sensitivity, beta cell potentiation factor, and beta cell rate sensitivity). In addition, we tested for interaction by sex and glucose metabolism status., Results: After full adjustment, lower time- and frequency-domain HRV was significantly associated with lower overall beta cell response composite score (standardized beta, -0.055 [-0.098; -0.011] and - 0.051 [-0.095; -0.007], respectively). These associations were not modified by sex and there was no consistent pattern of interaction by glucose metabolism status., Conclusion: The present etiological study found that worse autonomic function, estimated from lower HRV, was associated with worse beta cell function, estimated from a composite score in a population-based sample which covered the entire spectrum of glucose metabolism. Hence, autonomic dysfunction may contribute to beta cell dysfunction and, ultimately, to the alteration of glucose metabolism status from normal glucose metabolism to prediabetes and type 2 diabetes., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
29. Assessing attitudes towards insulin pump therapy in adults with type 1 diabetes: Italian validation of the Insulin Pump Attitudes Questionnaire (IT-IPA questionnaire).
- Author
-
Messina R, Indelicato L, Iommi M, Trombetta M, Roos T, Hermanns N, Di Sipio A, Fantini MP, and Calvo V
- Subjects
- Adult, Humans, Hypoglycemic Agents therapeutic use, Cross-Sectional Studies, Surveys and Questionnaires, Insulin therapeutic use, Insulin Infusion Systems, Patient Satisfaction, Italy, Diabetes Mellitus, Type 1 drug therapy, Diabetes Mellitus, Type 1 diagnosis
- Abstract
Aims: The aim of the study was to adapt the German version of the insulin pump therapy (IPA) questionnaire to Italian (IT-IPA) and to evaluate its psychometric properties in adults with type 1 diabetes., Methods: We conducted a cross-sectional study, data were collected through an online survey. In addition to IT-IPA, questionnaires evaluating depression, anxiety, diabetes distress, self-efficacy, and treatment satisfaction were administered. The six factors identified in the IPA German version were assessed using confirmatory factor analysis; psychometric testing included construct validity and internal consistency., Results: The online survey was compiled by 182 individuals with type 1 diabetes: 45.6% continuous subcutaneous insulin infusion (CSII) users and 54.4% multiple daily insulin injection users. The six-factor model had a very good fit in our sample. The internal consistency was acceptable (Cronbach's α = 0.75; 95% IC [0.65-0.81]). Diabetes treatment satisfaction was positively correlated with a positive attitude towards CSII therapy (Spearman's rho = 0.31; p < 0.01), less Technology Dependency, higher Ease of Use, and less Impaired Body Image. Furthermore, less Technology Dependency was associated with lower diabetes distress and depressive symptoms., Conclusions: The IT-IPA is a valid and reliable questionnaire evaluating attitudes towards insulin pump therapy. The questionnaire can be used for clinical practice during consultations for shared decision-making to CSII therapy., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
30. Active breaks: a strategy to counteract sedentary behaviors for Health Promoting Schools. A discussion on their implementation in Italy.
- Author
-
Dallolio L, Gallè F, Masini A, Valeriani F, Ceciliani A, di Cagno A, Galeone D, Pecoraro P, Valerio G, Liguori G, Romano Spica V, Brandi G, Baldelli G, Capelli G, Coco D, Corradi M, Cortis E, Deiana P, Di Rosa E, Marini S, Mulato R, Parisi A, Pesce C, Riegger S, Staiano A, Siniscalco A, Trombetta M, and Ubaldi F
- Subjects
- Humans, School Health Services, Exercise, Schools, Health Promotion, Sedentary Behavior
- Abstract
Abstract: School Active Breaks are short bouts of physical activity (5-15 minutes) conducted by appropriately trained teachers and delivered during or between curricular lessons. They are a good strategy to counteract sedentary behaviors, and a growing body of evidence shows that they can represent also a tool to promote and improve health, school wellbeing and academic achievements. On 19 February 2022, the Working Group on Movement Sciences for Health of the Italian Society of Hygiene, Preventive Medicine and Public Health organized an Awareness Day on the effectiveness, usefulness and feasibility of School Active Breaks, opened to teachers, educators, school leaders, pediatricians, personnel from Departments of Prevention and Public Health and Health Policy-makers. During the event, the testimonies about the experiences already carried out in Italy showed that School Active Breaks are an effective intervention that each school can easily include in its educational offer and apply in any context.
- Published
- 2023
- Full Text
- View/download PDF
31. Markers of subclinical vascular damage in young adults with type 1 diabetes mellitus: the role of central blood pressure.
- Author
-
Marcon D, Tagetti A, Piona C, Giontella A, Bortolotti S, Bonafini S, Carletti L, Morandi A, Trombetta M, Maffeis C, and Fava C
- Subjects
- Young Adult, Humans, Adolescent, Adult, Pulse Wave Analysis, Blood Pressure, Carotid Intima-Media Thickness, Risk Factors, Biomarkers, Diabetes Mellitus, Type 1 complications, Vascular Stiffness physiology
- Abstract
Introduction: Type 1 diabetes mellitus (T1D) is a chronic disease leading to cardiovascular complications that can be diagnosed early as subclinical vascular damage. To prevent such damage, it is important to increase knowledge of the effects of the different cardiovascular risk factors in patients with T1D. The aim of our study was to assess possible associations between markers of subclinical arterial damage and traditional cardiovascular risk factors, with a special focus on peripheral blood pressure and central blood pressure (cBP), in a sample of young adults with T1D., Patients and Methods: The study included 172 T1D patients (mean age 24.7 ± 8.7 years, duration of T1D 13.5 ± 9.6 years). Pulse wave velocity (PWV), pulse wave analysis and cBP were assessed by tonometry (SphygmoCor Xcel). Carotid intima-media thickness (cIMT) and carotid distensibility coefficient (cDC) were assessed by high-resolution echo-Doppler analysis and further examined with dedicated hardware., Results: Seventeen patients (10.1%) were classified as hypertensive by office peripheral blood pressure, and 48 patients (27.9%) were classified as hypertensive by cBP. One hundred sixteen patients (68.8%) had cDC under the range of normality, one patient had a PWV (0.6%) above 10 m/s, and no patients had a cIMT above 0.9 mm. In multivariable analysis, central SBP, but not metabolic parameters, remained associated with all the markers of subclinical arterial damage [cIMT ( β = 0.288 ± 0.001; P < 0.001), PWV ( β = 0.374 ± 0.007; P < 0.001), cDC ( β = -0.149 ± 0.055; P = 0.029)]., Conclusion: The independent association between cBP and markers of subclinical vascular damage underlines the importance of haemodynamic factors in the development of early signs of macrovascular disease in T1D patients. Further studies are warranted to better define the role of cBP to stratify cardiovascular risk, to individualize the need for follow-up and to tailor preventive strategies in T1D patients., (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
32. Accuracy of CGM Systems During Continuous and Interval Exercise in Adults with Type 1 Diabetes.
- Author
-
Da Prato G, Pasquini S, Rinaldi E, Lucianer T, Donà S, Santi L, Negri C, Bonora E, Moghetti P, and Trombetta M
- Subjects
- Adult, Humans, Blood Glucose Self-Monitoring, Insulin Infusion Systems, Blood Glucose, Exercise, Glucose, Reproducibility of Results, Diabetes Mellitus, Type 1
- Abstract
Background: continuous glucose monitoring systems (CGMs) play an important role in the management of T1D, but their accuracy may reduce during rapid glucose excursions. The aim of study was to assess the accuracy of recent rt-CGMs available in Italy, in subjects with T1D during 2 sessions of physical activity: moderate continuous (CON) and interval exercise (IE)., Method: we recruited 22 patients with T1D, on CSII associated or integrated with a CGM, to which a second different sensor was applied. Data recorded by CGMs were compared with the corresponding plasma glucose (PG) values, measured every 5 minutes with the glucose analyzer. To assess the accuracy of the CGMs, we evaluated the Sensor Bias (SB), the Mean Absolute Relative Difference (MARD) and the Clarke error grid (CEG)., Results: a total of 2355 plasma-sensor glucose paired points were collected. Both average plasma and interstitial glucose concentrations did not significantly differ during CON and IE. During CON: 1. PG change at the end of exercise was greater than during IE ( P = .034); 2. all sensors overestimated PG more than during IE, as shown by SB ( P < .001) and MARD ( P < .001) comparisons. Classifying the performance according to the CEG, significant differences were found between the 2 sessions in distribution of points in A and B zones., Conclusions: the exercise affects the accuracy of currently available CGMs, especially during CON, suggesting, in this circumstance, the need to maintain blood glucose in a "prudent" range, above that generally recommended. Further studies are needed to investigate additional types of activities.
- Published
- 2022
- Full Text
- View/download PDF
33. Insulin resistance and beta-cell dysfunction in newly diagnosed type 2 diabetes: Expression, aggregation and predominance. Verona Newly Diagnosed Type 2 Diabetes Study 10.
- Author
-
Bonora E, Trombetta M, Dauriz M, Brangani C, Cacciatori V, Negri C, Pichiri I, Stoico V, Rinaldi E, Da Prato G, Boselli ML, Santi L, Moschetta F, Zardini M, and Bonadonna RC
- Subjects
- Blood Glucose analysis, C-Peptide, Glucose, Glycated Hemoglobin analysis, Humans, Insulin, Diabetes Mellitus, Type 2, Hyperglycemia, Insulin Resistance physiology
- Abstract
Aims: We investigated quantitative expression, mutual aggregation and relation with hyperglycemia of insulin resistance (IR) and beta-cell dysfunction (BCD) in newly diagnosed type 2 diabetes., Methods: We assessed IR with euglycemic hyperinsulinemic clamp and BCD with modelled glucose/C-peptide response to oral glucose in 729 mostly drug-naïve patients. We measured glycated hemoglobin, pre-prandial, post-prandial and meal-related excursion of blood glucose., Results: IR was found in 87.8% [95% confidence intervals 85.4-90.2] and BCD in 90.0% [87.8-92.2] of subjects, ranging from mild to moderate or severe. Approximately 20% of subjects had solely one defect: BCD 10.8% [8.6-13.1] or IR 8.6% [6.6-10.7]. Insulin resistance and BCD aggregated in most subjects (79.1% [76.2-82.1]). We arbitrarily set nine possible combinations of mild, moderate or severe IR and mild, moderate or severe BCD, finding that each had a similar frequency (∼10%). In multiple regression analyses parameters of glucose control were related more strongly with BCD than with IR., Conclusions: In newly-diagnosed type 2 diabetes, IR and BCD are very common with a wide range of expression but no specific pattern of aggregation. Beta-cell dysfunction is likely to play a greater quantitative role than IR in causing/sustaining hyperglycemia in newly-diagnosed type 2 diabetes., (© 2022 The Authors. Diabetes/Metabolism Research and Reviews published by John Wiley & Sons Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
34. Droplet-based microfluidic synthesis of nanogels for controlled drug delivery: tailoring nanomaterial properties via pneumatically actuated flow-focusing junction.
- Author
-
Giannitelli SM, Limiti E, Mozetic P, Pinelli F, Han X, Abbruzzese F, Basoli F, Del Rio D, Scialla S, Rossi F, Trombetta M, Rosanò L, Gigli G, Zhang ZJ, Mauri E, and Rainer A
- Subjects
- Drug Delivery Systems, Microfluidics methods, Nanogels, Reproducibility of Results, Nanoparticles, Nanostructures
- Abstract
Conventional batch syntheses of polymer-based nanoparticles show considerable shortcomings in terms of scarce control over nanomaterials morphology and limited lot-to-lot reproducibility. Droplet-based microfluidics represents a valuable strategy to overcome these constraints, exploiting the formation of nanoparticles within discrete microdroplets. In this work, we synthesized nanogels (NGs) composed of hyaluronic acid and polyethyleneimine using a microfluidic flow-focusing device endowed with a pressure-driven micro-actuator. The actuator achieves real-time modulation of the junction orifice width, thereby regulating the microdroplet diameter and, as a result, the NG size. Acting on process parameters, NG hydrodynamic diameter could be tuned in the range 92-190 nm while preserving an extremely low polydispersity (0.015); those values are hardly achievable in batch syntheses and underline the strength of our toolbox for the continuous in-flow synthesis of nanocarriers. Furthermore, NGs were validated in vitro as a drug delivery system in a representative case study still lacking an effective therapeutic treatment: ovarian cancer. Using doxorubicin as a chemotherapeutic agent, we show that NG-mediated release of the drug results in an enhanced antiblastic effect vs . the non-encapsulated administration route even at sublethal dosages, highlighting the wide applicability of our microfluidics-enabled nanomaterials in healthcare scenarios.
- Published
- 2022
- Full Text
- View/download PDF
35. Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis.
- Author
-
Piona C, Mozzillo E, Tosco A, Volpi S, Rosanio FM, Cimbalo C, Franzese A, Raia V, Zusi C, Emiliani F, Boselli ML, Trombetta M, Bonadonna RC, Cipolli M, and Maffeis C
- Abstract
Background: To date, no consistent data are available on the possible impact of CFTR modulators on glucose metabolism. The aim of this study was to test the hypothesis that treatment with CFTR modulators is associated with an improvement in the key direct determinants of glucose regulation in children and young adults affected by Cystic Fibrosis (CF)., Methods: In this study, 21 CF patients aged 10-25 underwent oral glucose tolerance test (OGTT) before and after 12-18 months of treatment with Lumacaftor/Ivacaftor or Elexacaftor-Ivacaftor-Tezacaftor. β-cell function (i.e., first and second phase of insulin secretion measured as derivative and proportional control, respectively) and insulin clearance were estimated by OGTT mathematical modelling. Insulin sensitivity was estimated by the Oral Glucose Sensitivity Index (OGIS). The dynamic interplay between β-cell function, insulin clearance and insulin sensitivity was analysed by vector plots of glucose-stimulated insulin bioavailability vs. insulin sensitivity., Results: No changes in glucose tolerance occurred after either treatment, whereas a significant improvement in pulmonary function and chronic bacterial infection was observed. Beta cell function and insulin clearance did not change in both treatment groups. Insulin sensitivity worsened in the Lumacaftor/Ivacaftor group. The analysis of vector plots confirmed that glucose regulation was stable in both groups., Conclusions: Treatment of CF patients with CFTR modulators does not significantly ameliorate glucose homeostasis and/or any of its direct determinants.
- Published
- 2022
- Full Text
- View/download PDF
36. A Soft Zwitterionic Hydrogel as Potential Coating on a Polyimide Surface to Reduce Foreign Body Reaction to Intraneural Electrodes.
- Author
-
Gori M, Giannitelli SM, Vadalà G, Papalia R, Zollo L, Sanchez M, Trombetta M, Rainer A, Di Pino G, and Denaro V
- Subjects
- Electrodes, Humans, Methacrylates chemistry, Polyethylene Glycols chemistry, Foreign-Body Reaction prevention & control, Hydrogels chemistry
- Abstract
Invasive intraneural electrodes can control advanced neural-interfaced prostheses in human amputees. Nevertheless, in chronic implants, the progressive formation of a fibrotic capsule can gradually isolate the electrode surface from the surrounding tissue leading to loss of functionality. This is due to a nonspecific inflammatory response called foreign-body reaction (FBR). The commonly used poly(ethylene glycol) (PEG)-based low-fouling coatings of implantable devices can be easily encapsulated and are susceptible to oxidative damage in long-term in vivo applications. Recently, sulfobetaine-based zwitterionic hydrogels have emerged as an important class of robust ultra-low fouling biomaterials, holding great potential to mitigate FBR. The aim of this proof-of-principle in vitro work was to assess whether the organic zwitterionic-poly(sulfobetaine methacrylate) [poly(SBMA)]-hydrogel could be a suitable coating for Polyimide (PI)-based intraneural electrodes to reduce FBR. We first synthesized and analyzed the hydrogel through a mechanical characterization (i.e., Young's modulus). Then, we demonstrated reduced adhesion and activation of fibrogenic and pro-inflammatory cells (i.e., human myofibroblasts and macrophages) on the hydrogel compared with PEG-coated and polystyrene surfaces using cell viability assays, confocal fluorescence microscopy and high-content analysis of oxidative stress production. Interestingly, we successfully coated PI surfaces with a thin film of the hydrogel through covalent bond and demonstrated its high hydrophilicity via water contact angle measurement. Importantly, we showed the long-term release of an anti-fibrotic drug (i.e., Everolimus) from the hydrogel. Because of the low stiffness, biocompatibility, high hydration and ultra-low fouling characteristics, our zwitterionic hydrogel could be envisioned as long-term diffusion-based delivery system for slow and controlled anti-inflammatory and anti-fibrotic drug release in vivo.
- Published
- 2022
- Full Text
- View/download PDF
37. Growing up with type 1 diabetes mellitus: Data from the Verona Diabetes Transition Project.
- Author
-
Pasquini S, Rinaldi E, Da Prato G, Csermely A, Indelicato L, Zaffani S, Santi L, Sabbion A, Maffeis C, Bonora E, and Trombetta M
- Subjects
- Adolescent, Blood Glucose, Child, Female, Glycated Hemoglobin analysis, Humans, Male, Young Adult, Diabetes Mellitus, Type 1 epidemiology, Diabetes Mellitus, Type 1 psychology, Diabetes Mellitus, Type 1 therapy, Transition to Adult Care
- Abstract
Aim: Transition from paediatric to adult care is a critical step in life of emerging adults with type 1 diabetes. We assessed, according to indicators established by panel of experts, clinical, socio-demographic and psychosocial factors in young adults with type 1 diabetes throughout structured transition to investigate the associations, if any, with HbA
1c value at time of transition., Methods: The "Verona Diabetes Transition Project" started in January 2009: a structured transition program, shared between paediatric and adult clinic, was organised with a multi-disciplinary team. All young adults underwent a semi-structured interview by a psychologist, before transition. Minimum age for transition was 18 years., Results: 222 (M/F = 113/109) young adults moved to adult care from January 2009 to March 2020. The mean time between the last paediatric visit and the first adult visit ranged from 13.6 ± 6.1 months at the beginning of the project to 3.6 ± 11.5 months over the following years. At first adult clinic attendance, women showed higher HbA1c values (70 ± 11 mmol/mol vs. 65 ± 7 mmol/mol or 8.57% ± 1.51% vs. 8.14% ± 0.98%, p = 0.01), higher frequency of disorders of eating behaviours (15.6% vs. 0%, p < 0.001) and poor diabetes acceptance (23.9% vs. 9.7%, p < 0.001) than men. Mediation analyses showed a significant mediating role of glucose control 2 years before transition in the relationship between poor diabetes acceptance and glucose control at transition., Conclusions: This study demonstrated a delay reduction in establishing care with an adult provider and suggested the potential role of low diabetes acceptance on glycemic control at transition. Further studies are needed to confirm and expand these data., (© 2021 Diabetes UK.)- Published
- 2022
- Full Text
- View/download PDF
38. Effects of Semaglutide on Glycemic Control and Weight Loss in a Patient with Prader-Willi Syndrome: A Case Report.
- Author
-
Sani E, Prato GD, Zenti MG, Bordugo A, Trombetta M, and Bonora E
- Subjects
- Adult, Glucagon-Like Peptides pharmacology, Glucagon-Like Peptides therapeutic use, Glycemic Control, Humans, Hypoglycemic Agents pharmacology, Insulin, Liraglutide adverse effects, Male, Obesity complications, Obesity drug therapy, Weight Loss, Diabetes Mellitus, Type 2 complications, Diabetes Mellitus, Type 2 drug therapy, Prader-Willi Syndrome complications, Prader-Willi Syndrome drug therapy, Prader-Willi Syndrome metabolism
- Abstract
Background: Prader-Willi syndrome is the most frequent genetic cause of obesity and is often complicated by glucose metabolism alterations. Conventional therapies prescribed for type 2 diabetes frequently failed to achieve adequate glycemic control in patients with Prader-Willi syndrome. Beneficial effects of glucagon like peptide-1 receptor agonists exenatide and liraglutide have been reported for the management of type 2 diabetes in Prader-Willi syndrome, but no data are currently available in this population on the use of semaglutide., Case Presentation: We report for the first time the use of semaglutide 1 mg per week in a 33-yearold man with Prader-Will syndrome complicated by poorly controlled diabetes and severe obesity. After 12 months of semaglutide treatment, we observed an important reduction in glycated hemoglobin levels (11.1% to 7.2%) and body weight (99.5 kg to 94.3 kg), with a notable decrease in fat mass and insulin requirements. Interestingly, our patient had already tried liraglutide therapy in adjunction to metformin and insulin therapy, reporting no substantial efficacy., Conclusion: The beneficial effects of semaglutide on glycemic control and weight reduction provide a promising treatment for diabetes and obesity in Prader-Willi syndrome, even where other glucagons like peptide-1 receptor agonists have failed. Further studies are required to confirm the efficacy and safety of semaglutide in patients with Prader-Willi syndrome., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.